Cytokinetics COO Executes Back‑to‑Back Buy‑Sell: $23.26 Buy, $61.93 Sale Sparks Insider Strategy Speculation
Callos Andrew’s back‑to‑back buy‑sell of Cytokinetics shares signals strategic rebalancing, hinting insider confidence amid upcoming MYQORZO milestones.
3 minutes to read